Issue 11, 2016

Potent sirtuin inhibition with 1,2,5-trisubstituted benzimidazoles

Abstract

Two series of compounds were synthesized based on the benzimidazole scaffold. The compounds were subsequently screened for their SIRT1, SIRT2 and SIRT3 activities. Three of the compounds showed good inhibitory activity against SIRT2 in this study with the most potent compound (5i) having an IC50 value of 2.9 μM. Molecular docking analysis demonstrated that 5i was able to inhibit SIRT2 by displacing the co-factor NAD+ in the active site. This was further confirmed experimentally by ligand-NAD+ competitive assay.

Graphical abstract: Potent sirtuin inhibition with 1,2,5-trisubstituted benzimidazoles

Supplementary files

Article information

Article type
Research Article
Submitted
08 Jul 2016
Accepted
03 Aug 2016
First published
05 Aug 2016

Med. Chem. Commun., 2016,7, 2094-2099

Potent sirtuin inhibition with 1,2,5-trisubstituted benzimidazoles

Y. K. Yoon, H. Osman and T. S. Choon, Med. Chem. Commun., 2016, 7, 2094 DOI: 10.1039/C6MD00378H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements